PATENT CLAIM ANALYSIS

Application Number: 16004415
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["530", "387300"]

Abstract:
This disclosure provides reagent to treat tumor and cancer, and methods of using the same for treating tumor and cancer. One type of the reagent is pro-antibody, which is antibody that can be activated in tumor. Another type of the reagent is a conjugate of sialidase with affinity ligand that can bind to immuno cell surface or a conjugate of sialidase with affinity ligand that can bind to another antibody, therefore provide a sialidase based cancer immuno therapy strategy.

Claim (Index 6):
A conjugate to treat cancer comprising a sialidase and an affinity ligand that can bind to a cancer cell binding antibody.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.80851
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15124058', '12101999', '11101018', '11233258', '10410962']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5793390907473417
- 35 USC 102 Novelty (BERT): 0.4712552513905936
- Combined Prediction Score: 0.5685307068116668
- Mean Citation Score: 142.67061399999997
- Max Citation Score: 154.60454
- Similarity Product: 117.72299921758292

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test